Impilo

Headquarters
SwedenStockholm, Sweden
Founded
Founded 2017
Company size
11-50 employees
LinkedIn
LinkedIn
United KingdomUkraineTurkeySwitzerlandSwedenSpainSlovakiaSloveniaSerbiaRomaniaPortugalPolandNorwayNetherlandsMontenegroMoldovaMaltaNorth MacedoniaLuxembourgLithuaniaLatviaKosovoItalyIrelandIcelandHungaryGreeceGermanyFranceFinlandEstoniaDenmarkCzech RepublicCyprusCroatiaBulgariaBosniaBelgiumBelarusAustriaAlbania
Headquartered in Stockholm, Sweden

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds
1
Reported volume
€700m
Latest public closing
3 Jun 2025

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Stockholm-based private equity firm investing in healthcare businesses.

Focus: Healthcare-related businesses, including pharmaceuticals, medical technology and healthcare services

23 April 2024: Impilo reached the final close of Impilo Fund II at €700m, raised over seven months after its formal launch (company news).

Tracked funds

Showing 1 of 1 funds